Literature DB >> 10571714

Ethnic differences in hormone replacement prescribing patterns.

A F Brown1, E J Pérez-Stable, E E Whitaker, S F Posner, M Alexander, J Gathe, A E Washington.   

Abstract

OBJECTIVE: To determine whether prescription patterns of hormone replacement therapy (HRT) differ in African-American, Asian, Latina, Soviet immigrant, and white women.
DESIGN: Retrospective review of computerized medical records.
SETTING: The general internal medicine, family medicine, and gynecology practices of an academic medical center. PATIENTS: Women aged 50 years or older with at least one outpatient visit from January 1, 1992, to November 30, 1995.
MEASUREMENTS AND MAIN RESULTS: Use of HRT was defined as documentation of systemic estrogen use. The main predictor variable was self-identified ethnicity. Age, diagnosis (coronary heart disease, hypertension, diabetes, osteoporosis, or breast cancer), and median income were included in the analysis. Of the 8,968 women (mean age, 65.4 years) included, 50% were white, 20% Asian, 15% African American, 9% Latina, and 6% Soviet immigrants. Whites (33%) were significantly more likely to be prescribed HRT than Asians (21%), African Americans (25%), Latinas (23%), or Soviet immigrants (6.6%), p < 0.01 for each. Multivariate analysis, comparing ethnic groups and controlling for confounding variables, showed that Asians (odds ratio [OR] 0.56; 95% confidence interval [CI] 0.49, 0.64), African Americans (OR 0.70; 95% CI 0.60, 0.81), Latinas (OR 0.70; 95% CI 0.58, 0.84), and Soviet immigrants (OR 0.14; 95% CI 0.10, 0. 20) were each less likely to be prescribed HRT than were white women. Although women with osteoporosis were more likely to receive HRT (OR 2.28; 95% CI 1.71, 2.99), those with coronary heart disease were not (OR 0.88; 95% CI 0.68, 1.09).
CONCLUSIONS: Physicians at this medical center were more likely to prescribe HRT for white women and women with osteoporosis. Further study is needed to address whether these differences in HRT prescribing result in different health outcomes.

Entities:  

Mesh:

Year:  1999        PMID: 10571714      PMCID: PMC1496759          DOI: 10.1046/j.1525-1497.1999.10118.x

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  51 in total

1.  The climacteric, osteoporosis and hormone replacement; views of women aged 45-49.

Authors:  M Garton; D Reid; E Rennie
Journal:  Maturitas       Date:  1995-01       Impact factor: 4.342

2.  Racial and ethnic differences in the use of invasive cardiac procedures among cardiac patients in Los Angeles County, 1986 through 1988.

Authors:  D M Carlisle; B D Leake; M F Shapiro
Journal:  Am J Public Health       Date:  1995-03       Impact factor: 9.308

3.  Use of hormone replacement therapy by postmenopausal women in the United States.

Authors:  N L Keating; P D Cleary; A S Rossi; A M Zaslavsky; J Z Ayanian
Journal:  Ann Intern Med       Date:  1999-04-06       Impact factor: 25.391

Review 4.  Hormone replacement therapy for African American women: missed opportunities for effective intervention.

Authors:  W K Nicholson; A F Brown; J Gathe; K Grumbach; A E Washington; E J Pérez-Stable
Journal:  Menopause       Date:  1999       Impact factor: 2.953

5.  Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group.

Authors:  S Hulley; D Grady; T Bush; C Furberg; D Herrington; B Riggs; E Vittinghoff
Journal:  JAMA       Date:  1998-08-19       Impact factor: 56.272

6.  The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.

Authors:  G A Colditz; S E Hankinson; D J Hunter; W C Willett; J E Manson; M J Stampfer; C Hennekens; B Rosner; F E Speizer
Journal:  N Engl J Med       Date:  1995-06-15       Impact factor: 91.245

7.  A survey of views on hormone replacement therapy.

Authors:  S G Norman; J W Studd
Journal:  Br J Obstet Gynaecol       Date:  1994-10

8.  Hormone replacement therapy and endometrial cancer risk: a meta-analysis.

Authors:  D Grady; T Gebretsadik; K Kerlikowske; V Ernster; D Petitti
Journal:  Obstet Gynecol       Date:  1995-02       Impact factor: 7.661

9.  Issues in the provision of health care to Soviet emigrants.

Authors:  P J Cronkright; K DeHaven; I A Kraev
Journal:  Arch Fam Med       Date:  1993-04

10.  Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group.

Authors:  S R Cummings; M C Nevitt; W S Browner; K Stone; K M Fox; K E Ensrud; J Cauley; D Black; T M Vogt
Journal:  N Engl J Med       Date:  1995-03-23       Impact factor: 91.245

View more
  15 in total

Review 1.  Toward improved health: disaggregating Asian American and Native Hawaiian/Pacific Islander data.

Authors:  S Srinivasan; T Guillermo
Journal:  Am J Public Health       Date:  2000-11       Impact factor: 9.308

2.  Long-term effect of the Women's Health Initiative study on antiosteoporosis medication prescribing.

Authors:  Euni Lee; Mary K Maneno; Anthony K Wutoh; Ilene H Zuckerman
Journal:  J Womens Health (Larchmt)       Date:  2010-05       Impact factor: 2.681

3.  Racial variations in antiresorptive medication use: results from the 2000 Medical Expenditure Panel Survey (MEPS).

Authors:  Joel F Farley; Richard R Cline; Kiran Gupta
Journal:  Osteoporos Int       Date:  2005-11-29       Impact factor: 4.507

4.  The associations of hormone replacement therapy and preventive practices in minority women.

Authors:  Kalpana Ganesan; Senait Teklehaimanot; Merlyn Asuncion
Journal:  J Natl Med Assoc       Date:  2005-01       Impact factor: 1.798

5.  Estrogen alone and health outcomes in black women by African ancestry: a secondary analyses of a randomized controlled trial.

Authors:  Rowan T Chlebowski; Wendy Barrington; Aaron K Aragaki; JoAnn E Manson; Gloria Sarto; Mary J OʼSullivan; Daniel Wu; Jane A Cauley; Lihong Qi; Robert L Wallace; Ross L Prentice
Journal:  Menopause       Date:  2017-02       Impact factor: 2.953

6.  Tubal ligation and ovarian cancer risk in African American women.

Authors:  Chrissy McNamara; Sarah E Abbott; Elisa V Bandera; Bo Qin; Lauren C Peres; Fabian Camacho; Patricia G Moorman; Anthony J Alberg; Jill S Barnholtz-Sloan; Melissa Bondy; Michele L Cote; Ellen Funkhouser; Edward S Peters; Ann G Schwartz; Joellen M Schildkraut; Paul Terry
Journal:  Cancer Causes Control       Date:  2017-09-04       Impact factor: 2.506

7.  Ethnic and geographic variations in corpus uteri cancer burden: evidence based on data from 29 states and the District of Columbia. CI5 IX, X and SEER data (1998-2010).

Authors:  Dominique Sighoko
Journal:  Cancer Causes Control       Date:  2014-07-03       Impact factor: 2.506

8.  A situation-specific theory of Asian immigrant women's menopausal symptom experience in the United States.

Authors:  Eun-Ok Im
Journal:  ANS Adv Nurs Sci       Date:  2010 Apr-Jun       Impact factor: 1.824

9.  Osteoporosis medications used by older African-American women: effects of socioeconomic status and psychosocial factors.

Authors:  Christine G Unson; Richard Fortinsky; Karen Prestwood; Susan Reisine
Journal:  J Community Health       Date:  2005-08

10.  Application of high-resolution skeletal imaging to measurements of volumetric BMD and skeletal microarchitecture in Chinese-American and white women: explanation of a paradox.

Authors:  Marcella D Walker; Donald J McMahon; Julia Udesky; George Liu; John P Bilezikian
Journal:  J Bone Miner Res       Date:  2009-12       Impact factor: 6.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.